Shayla Pullen, MD
Sleep Medicine · Cincinnati, OHNPI 1174639058
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $44,126 of the $70,703 with a category attached, or 62.4%. 20 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 39.9% of the total. 2025 is the largest year on record at $39,219, more than ten times the $404 reported in 2019. Among sleep medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $162.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$28K
- Avadel CNS Pharmaceuticals, LLC$26K
- Lilly USA, LLC$8K
- ZOLL Respicardia, Inc.$4K
- Harmony Biosciences LLC$2K
- Axsome Therapeutics, Inc.$651
- plus $2K from 14 others
What the payments were for
- Consulting fees$7,77211%
- Speaking & faculty fees$44,12662%
- Travel & lodging$8,50812%
- Food & beverage$9,56614%
- Education$7321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 122 | $28,188 |
| Avadel CNS Pharmaceuticals, LLC | 30 | $25,864 |
| Lilly USA, LLC | 22 | $8,126 |
| ZOLL Respicardia, Inc. | 10 | $4,296 |
| Harmony Biosciences LLC | 158 | $1,985 |
| Axsome Therapeutics, Inc. | 25 | $651 |
| Inspire Medical Systems, Inc. | 13 | $454 |
| Idorsia Pharmaceuticals US Inc | 18 | $343 |
| Fisher & Paykel Healthcare Inc | 7 | $263 |
| Merck | 9 | $158 |
| Vanda Pharmaceuticals Inc. | 8 | $158 |
| Resmed Corp | 2 | $50 |
| Eisai Inc. | 3 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Mylan Specialty L.p. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $13 |
| 3b Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUMRYZ$25,506
- XYWAV$25,397
- ZEPBOUND$7,820
- remede System$4,207
- SUNOSI$462
- Inspire$148
- XYREM$109
- Wakix$109
- QUVIVIQ$103
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment$100
How this compares
$70,703 in reported general payments places this provider in the 90th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 38 | $494,654 |
| BelsomraSuvorexant | 16 | $8,247 |
| QuviviqDaridorexant Hcl | 12 | $5,465 |
| Modafinil | 30 | $3,721 |
| Doxepin Hcl | 28 | $805 |
| Ropinirole Hcl | 29 | $690 |
| Zaleplon | 88 | $621 |
| Zolpidem Tartrate | 33 | $343 |
| Gabapentin | 41 | $314 |
| Clonazepam | 24 | $225 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 16 | $219 |
| Trazodone Hcl | 42 | $128 |
| Alprazolam | 13 | $85 |
| Temazepam | 17 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $158 | $8,24716 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $343 | $5,46512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Cincinnati
- Shahrokh JavaheriCincinnati$404K
- Anthony SuchoskiCincinnati$89K
- Sunil DamaCincinnati$7K
- Omdevasena ThirugnanamCincinnati$7K
- Karthikeyan KanagarajanCincinnati$6K
- Chiranjeevi Pramodna SiddaguntaCincinnati$3K
- Bashar BrijawiCincinnati$3K
- Ann RomakerCincinnati$2K
- Roma UyCincinnati$1K
- Asim RoyDublin$666K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.